These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Araújo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042 [TBL] [Abstract][Full Text] [Related]
4. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen. González-Mira E; Nikolić S; García ML; Egea MA; Souto EB; Calpena AC J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052 [TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Luo Q; Zhao J; Zhang X; Pan W Int J Pharm; 2011 Jan; 403(1-2):185-91. PubMed ID: 20951778 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil. Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496 [TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation. Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987 [TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. Shen J; Wang Y; Ping Q; Xiao Y; Huang X J Control Release; 2009 Aug; 137(3):217-23. PubMed ID: 19393270 [TBL] [Abstract][Full Text] [Related]
10. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384 [TBL] [Abstract][Full Text] [Related]
11. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990 [TBL] [Abstract][Full Text] [Related]
12. Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogels. Gonzalez-Mira E; Nikolić S; Calpena AC; Egea MA; Souto EB; García ML J Pharm Sci; 2012 Feb; 101(2):707-25. PubMed ID: 22012873 [TBL] [Abstract][Full Text] [Related]
13. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables. Rathod VR; Shah DA; Dave RH Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896 [TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):167-73. PubMed ID: 16198092 [TBL] [Abstract][Full Text] [Related]
15. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability. Teeranachaideekul V; Müller RH; Junyaprasert VB Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778 [TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487 [TBL] [Abstract][Full Text] [Related]
17. Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method. Kovács A; Berkó S; Csányi E; Csóka I Eur J Pharm Sci; 2017 Mar; 99():246-257. PubMed ID: 28012940 [TBL] [Abstract][Full Text] [Related]
18. Physical and chemical stability of nanostructured lipid drug carriers (NLC) based on natural lipids from Baikal region (Siberia, Russia). Averina ES; Müller RH; Popov DV; Radnaeva LD Pharmazie; 2011 May; 66(5):348-56. PubMed ID: 21699068 [TBL] [Abstract][Full Text] [Related]
19. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405 [TBL] [Abstract][Full Text] [Related]
20. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery. Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]